Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
companion diagnostic
MedTech
Roche Diagnostics growth remains muted amid China headwinds
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.
Ben Adams
Jul 23, 2026 8:13am
Promega wins FDA OK as Keytruda-Lenvima companion diagnostic
Nov 13, 2025 4:00am
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am
Caris Life Sciences collects $168M to fund tumor test rollouts
Apr 9, 2025 11:51am
Roche companion test moves into HER2-ultralow breast cancer
Feb 4, 2025 12:00pm
FDA approves Caris multi-cancer companion diagnostic test
Nov 13, 2024 9:00am
